SHE · Healthcare

Shenzhen Bioeasy Biotechnology Co. Ltd. (300942)

Biotechnology

Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) is listed on SHE in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported market cap is $3.47B, P/E ratio is 107.00, net margin is 12.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 300942

Market cap
$3.47B
P/E ratio
107.00
Gross profit (TTM)
$171.02M
Net margin
12.4%

Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — FAQ

What is Shenzhen Bioeasy Biotechnology Co. Ltd.'s market cap?

Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a reported market cap of $3.47B (data as of 2026-03-28).

What is 300942's P/E ratio?

The price-to-earnings (P/E) ratio for Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) is 107.00 (data as of 2026-03-28).

Does Shenzhen Bioeasy Biotechnology Co. Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Shenzhen Bioeasy Biotechnology Co. Ltd. (300942). Check the MyAverix Finance app for the latest dividend data.

What sector is Shenzhen Bioeasy Biotechnology Co. Ltd. in?

Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 300942 listed on?

300942 is listed on SHE.

What is Shenzhen Bioeasy Biotechnology Co. Ltd.'s net margin?

Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) reports a net margin of 12.4% (data as of 2026-03-28).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play